ABT
Price
$131.69
Change
-$0.96 (-0.72%)
Updated
Apr 1 closing price
Capitalization
194.5B
14 days until earnings call
HOLX
Price
$61.38
Change
-$0.39 (-0.63%)
Updated
Apr 1 closing price
Capitalization
17.87B
28 days until earnings call
Ad is loading...

ABT vs HOLX

Header iconABT vs HOLX Comparison
Open Charts ABT vs HOLXBanner chart's image
Abbott Laboratories
Price$131.69
Change-$0.96 (-0.72%)
Volume$4.23M
Capitalization194.5B
Hologic
Price$61.38
Change-$0.39 (-0.63%)
Volume$1.52M
Capitalization17.87B
ABT vs HOLX Comparison Chart
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. HOLX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Buy and HOLX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ABT: $131.69 vs. HOLX: $61.77)
Brand notoriety: ABT: Notable vs. HOLX: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 61% vs. HOLX: 85%
Market capitalization -- ABT: $194.5B vs. HOLX: $17.87B
ABT [@Medical Specialties] is valued at $194.5B. HOLX’s [@Medical Specialties] market capitalization is $17.87B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 3 FA rating(s) are green whileHOLX’s FA Score has 0 green FA rating(s).

  • ABT’s FA Score: 3 green, 2 red.
  • HOLX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABT is a better buy in the long-term than HOLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 5 TA indicator(s) are bullish while HOLX’s TA Score has 5 bullish TA indicator(s).

  • ABT’s TA Score: 5 bullish, 5 bearish.
  • HOLX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HOLX is a better buy in the short-term than ABT.

Price Growth

ABT (@Medical Specialties) experienced а +4.85% price change this week, while HOLX (@Medical Specialties) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.35%. For the same industry, the average monthly price growth was +2.11%, and the average quarterly price growth was +3.08%.

Reported Earning Dates

ABT is expected to report earnings on Apr 16, 2025.

HOLX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-3.35% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($194B) has a higher market cap than HOLX($17.9B). HOLX (36.08) and ABT (34.38) have similar P/E ratio . ABT YTD gains are higher at: 17.037 vs. HOLX (-14.315). ABT has higher annual earnings (EBITDA): 10.5B vs. HOLX (1.06B). ABT has more cash in the bank: 7.28B vs. HOLX (1.93B). HOLX has less debt than ABT: HOLX (2.58B) vs ABT (15.6B). ABT has higher revenues than HOLX: ABT (40.1B) vs HOLX (3.97B).
ABTHOLXABT / HOLX
Capitalization194B17.9B1,084%
EBITDA10.5B1.06B988%
Gain YTD17.037-14.315-119%
P/E Ratio34.3836.0895%
Revenue40.1B3.97B1,010%
Total Cash7.28B1.93B377%
Total Debt15.6B2.58B605%
FUNDAMENTALS RATINGS
ABT vs HOLX: Fundamental Ratings
ABT
HOLX
OUTLOOK RATING
1..100
7022
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
2655
SMR RATING
1..100
3254
PRICE GROWTH RATING
1..100
4563
P/E GROWTH RATING
1..100
9592
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (11) in the Medical Specialties industry is somewhat better than the same rating for HOLX (70). This means that ABT’s stock grew somewhat faster than HOLX’s over the last 12 months.

ABT's Profit vs Risk Rating (26) in the Medical Specialties industry is in the same range as HOLX (55). This means that ABT’s stock grew similarly to HOLX’s over the last 12 months.

ABT's SMR Rating (32) in the Medical Specialties industry is in the same range as HOLX (54). This means that ABT’s stock grew similarly to HOLX’s over the last 12 months.

ABT's Price Growth Rating (45) in the Medical Specialties industry is in the same range as HOLX (63). This means that ABT’s stock grew similarly to HOLX’s over the last 12 months.

HOLX's P/E Growth Rating (92) in the Medical Specialties industry is in the same range as ABT (95). This means that HOLX’s stock grew similarly to ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTHOLX
RSI
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 6 days ago
60%
Bullish Trend 6 days ago
55%
Declines
ODDS (%)
Bearish Trend 12 days ago
50%
Bearish Trend 13 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
54%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
47%
View a ticker or compare two or three
Ad is loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSVR7.630.38
+5.24%
Reservoir Media
ASND155.861.18
+0.76%
Ascendis Pharma A/S
HLP1.28N/A
-0.19%
Hongli Group
CCU15.20-0.12
-0.78%
Compania Cervecerias Unidas SA
HEPA0.43-0.05
-10.44%
Hepion Pharmaceuticals Inc